CC
SZYM

Cambrian Capital’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Cambrian Capital’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-106,387
Closed -$277K – 54
2015
Q3 		$277K Sell
106,387
-64,363
-38% -$168K 0.17% 45
2015
Q2 		$536K Hold
170,750
– – 0.24% 43
2015
Q1 		$488K Sell
170,750
-69,300
-29% -$177K 0.18% 45
2014
Q4 		$619K Buy
240,050
+170,750
+246% +$747K 0.22% 41
2014
Q3 		$517K Hold
69,300
– – 0.17% 53
2014
Q2 		$816K Hold
69,300
– – 0.21% 51
2014
Q1 		$805K Buy
+69,300
New +$815K 0.2% 49

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cambrian Capital's SZYM Position: Q4 2015 in Review

Cambrian Capital sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2015, closing a stake of 106,387 shares — an estimated $277K sold.

Cambrian Capital first reported a position in SZYM in Q1 2014 and held it in 7 quarters. The position peaked at $816K in Q2 2014. 108 funds tracked by Wall St. Rank hold SZYM as of Q4 2015.

  • Cambrian Capital reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Cambrian Capital sold 106,387 SOLAZYME INC COM STK (DE) shares in Q4 2015, an estimated $277K.
  • Cambrian Capital first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 7 quarters.
  • Cambrian Capital's SOLAZYME INC COM STK (DE) position peaked at $816K in Q2 2014.
  • 108 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2015.

Based on Cambrian Capital's 13F filing for Q4 2015, filed 16 Feb 2016.